Jafron Biomedical Co Ltd (300529) — Capital Reinvestment Ratio

Latest as of September 2025: 0.83x

Jafron Biomedical Co Ltd (300529) has a Capital Reinvestment Ratio of 0.83x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥35.34 Million) in capital expenditures (CN¥29.45 Million). See how much free cash does Jafron Biomedical Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.83x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥35.34 Million
CNY

Capital Expenditures

CN¥29.45 Million
CNY

Data as of

Sep 2025
Most recent filing

Jafron Biomedical Co Ltd Capital Reinvestment Ratio (2011–2025)

This chart tracks Jafron Biomedical Co Ltd's Capital Reinvestment Ratio across 15 annual periods.

Annual Capital Reinvestment Ratio for Jafron Biomedical Co Ltd (2011–2025)

Year-by-year Capital Reinvestment Ratio for Jafron Biomedical Co Ltd from 2011 to 2025. For live market cap and broader valuation context, see 300529 company net worth.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.24x CN¥721.22 Million CN¥172.59 Million ▲ +7.0%
2024 0.22x CN¥1.05 Billion CN¥235.14 Million ▼ -17.0%
2023 0.27x CN¥916.74 Million CN¥247.25 Million ▼ -49.9%
2022 0.54x CN¥883.80 Million CN¥475.89 Million ▲ +25.2%
2021 0.43x CN¥1.25 Billion CN¥537.41 Million ▲ +15.3%
2020 0.37x CN¥957.49 Million CN¥357.11 Million ▼ -1.4%
2019 0.38x CN¥583.50 Million CN¥220.67 Million ▼ -16.3%
2018 0.45x CN¥384.08 Million CN¥173.53 Million ▼ -22.7%
2017 0.58x CN¥304.10 Million CN¥177.73 Million ▲ +264.3%
2016 0.16x CN¥178.64 Million CN¥28.66 Million ▼ -46.4%
2015 0.30x CN¥205.18 Million CN¥61.40 Million ▼ -36.1%
2014 0.47x CN¥137.35 Million CN¥64.29 Million ▼ -1.2%
2013 0.47x CN¥133.33 Million CN¥63.14 Million ▲ +6.6%
2012 0.44x CN¥120.25 Million CN¥53.43 Million ▲ +134.8%
2011 0.19x CN¥77.06 Million CN¥14.58 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow